Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21507972rdf:typepubmed:Citationlld:pubmed
pubmed-article:21507972lifeskim:mentionsumls-concept:C0206419lld:lifeskim
pubmed-article:21507972lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:21507972lifeskim:mentionsumls-concept:C0598312lld:lifeskim
pubmed-article:21507972lifeskim:mentionsumls-concept:C0679199lld:lifeskim
pubmed-article:21507972lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:21507972pubmed:issue13lld:pubmed
pubmed-article:21507972pubmed:dateCreated2011-6-10lld:pubmed
pubmed-article:21507972pubmed:abstractTextCoronaviruses are a family of enveloped single-stranded positive-sense RNA viruses causing respiratory, enteric, and neurologic diseases in mammals and fowl. Human coronaviruses are recognized to cause up to a third of common colds and are suspected to be involved in enteric and neurologic diseases. Coronavirus replication involves the generation of nested subgenomic mRNAs (sgmRNAs) with a common capped 5' leader sequence. The translation of most of the sgmRNAs is thought to be cap dependent and displays a requirement for eukaryotic initiation factor 4F (eIF4F), a heterotrimeric complex needed for the recruitment of 40S ribosomes. We recently reported on an ultrahigh-throughput screen to discover compounds that inhibit eIF4F activity by blocking the interaction of two of its subunits (R. Cencic et al., Proc. Natl. Acad. Sci. U. S. A. 108:1046-1051, 2011). Herein we describe a molecule from this screen that prevents the interaction between eIF4E (the cap-binding protein) and eIF4G (a large scaffolding protein), inhibiting cap-dependent translation. This inhibitor significantly decreased human coronavirus 229E (HCoV-229E) replication, reducing the percentage of infected cells and intra- and extracellular infectious virus titers. Our results support the strategy of targeting the eIF4F complex to block coronavirus infection.lld:pubmed
pubmed-article:21507972pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21507972pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21507972pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21507972pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21507972pubmed:languageenglld:pubmed
pubmed-article:21507972pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21507972pubmed:citationSubsetIMlld:pubmed
pubmed-article:21507972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21507972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21507972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21507972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21507972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21507972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21507972pubmed:statusMEDLINElld:pubmed
pubmed-article:21507972pubmed:monthJullld:pubmed
pubmed-article:21507972pubmed:issn1098-5514lld:pubmed
pubmed-article:21507972pubmed:authorpubmed-author:VajdaSandorSlld:pubmed
pubmed-article:21507972pubmed:authorpubmed-author:PelletierJerr...lld:pubmed
pubmed-article:21507972pubmed:authorpubmed-author:HallDavid RDRlld:pubmed
pubmed-article:21507972pubmed:authorpubmed-author:DesforgesMarc...lld:pubmed
pubmed-article:21507972pubmed:authorpubmed-author:TalbotPierre...lld:pubmed
pubmed-article:21507972pubmed:authorpubmed-author:FuHaianHlld:pubmed
pubmed-article:21507972pubmed:authorpubmed-author:DingledineRay...lld:pubmed
pubmed-article:21507972pubmed:authorpubmed-author:MinJaekiJlld:pubmed
pubmed-article:21507972pubmed:authorpubmed-author:CencicReginaRlld:pubmed
pubmed-article:21507972pubmed:authorpubmed-author:KozakovDimaDlld:pubmed
pubmed-article:21507972pubmed:authorpubmed-author:DuYuhongYlld:pubmed
pubmed-article:21507972pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21507972pubmed:volume85lld:pubmed
pubmed-article:21507972pubmed:ownerNLMlld:pubmed
pubmed-article:21507972pubmed:authorsCompleteYlld:pubmed
pubmed-article:21507972pubmed:pagination6381-9lld:pubmed
pubmed-article:21507972pubmed:meshHeadingpubmed-meshheading:21507972...lld:pubmed
pubmed-article:21507972pubmed:meshHeadingpubmed-meshheading:21507972...lld:pubmed
pubmed-article:21507972pubmed:meshHeadingpubmed-meshheading:21507972...lld:pubmed
pubmed-article:21507972pubmed:meshHeadingpubmed-meshheading:21507972...lld:pubmed
pubmed-article:21507972pubmed:meshHeadingpubmed-meshheading:21507972...lld:pubmed
pubmed-article:21507972pubmed:meshHeadingpubmed-meshheading:21507972...lld:pubmed
pubmed-article:21507972pubmed:meshHeadingpubmed-meshheading:21507972...lld:pubmed
pubmed-article:21507972pubmed:meshHeadingpubmed-meshheading:21507972...lld:pubmed
pubmed-article:21507972pubmed:meshHeadingpubmed-meshheading:21507972...lld:pubmed
pubmed-article:21507972pubmed:meshHeadingpubmed-meshheading:21507972...lld:pubmed
pubmed-article:21507972pubmed:meshHeadingpubmed-meshheading:21507972...lld:pubmed
pubmed-article:21507972pubmed:meshHeadingpubmed-meshheading:21507972...lld:pubmed
pubmed-article:21507972pubmed:meshHeadingpubmed-meshheading:21507972...lld:pubmed
pubmed-article:21507972pubmed:year2011lld:pubmed
pubmed-article:21507972pubmed:articleTitleBlocking eIF4E-eIF4G interaction as a strategy to impair coronavirus replication.lld:pubmed
pubmed-article:21507972pubmed:affiliationMcIntyre Medical Sciences Building, Rm. 810, 3655 Promenade Sir William Osler, McGill University, Montreal, Quebec, Canada H3G 1Y6.lld:pubmed
pubmed-article:21507972pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21507972pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:21507972pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed